These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 3874793

  • 1. [Reevaluation of recalled infants by neonatal mass screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Diagnostic value of pregnanetriolone in a single urine specimen using glass capillary gas chromatography].
    Hikita Y.
    Nihon Naibunpi Gakkai Zasshi; 1985 Mar 20; 61(3):197-219. PubMed ID: 3874793
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Determination of urinary 17 alpha-hydroxyprogesterone excretion using ELISA--evaluation of normal subjects and patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    Shibata Y.
    Nihon Naibunpi Gakkai Zasshi; 1991 Aug 20; 67(8):819-39. PubMed ID: 1813324
    [Abstract] [Full Text] [Related]

  • 4. [Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 1. Enzyme immunoassay of dried blood 17 alpha-hydroxyprogesterone and its application to neonatal screening for congenital adrenal hyperplasia].
    Fukushi M, Arai O, Mizushima Y, Takasugi N, Fujieda K, Matsuura N.
    Nihon Naibunpi Gakkai Zasshi; 1986 Jun 20; 62(6):683-96. PubMed ID: 3530828
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Changes of several adrenal delta 4-steroids measured by HPLC-UV spectrometry in neonatal patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Saisho S, Shimozawa K, Yata J.
    Horm Res; 1990 Jun 20; 33(1):27-34. PubMed ID: 2376395
    [Abstract] [Full Text] [Related]

  • 7. A neonatal mass-screening for congenital adrenal hyperplasia in Japan.
    Shimozawa K, Saisho S, Saito N, Yata J, Igarashi Y, Hikita Y, Irie M, Okada K.
    Acta Endocrinol (Copenh); 1984 Dec 20; 107(4):513-8. PubMed ID: 6516697
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 3. An enzyme-linked immunosorbent assay for dried blood 17 alpha-hydroxyprogesterone].
    Fukushi M, Arai O, Mizushima Y, Takasugi N, Fujieda K, Matsuura N.
    Nihon Naibunpi Gakkai Zasshi; 1987 Feb 20; 63(2):113-22. PubMed ID: 3494638
    [Abstract] [Full Text] [Related]

  • 10. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
    Kopacek C, de Castro SM, Prado MJ, da Silva CM, Beltrão LA, Spritzer PM.
    BMC Pediatr; 2017 Jan 17; 17(1):22. PubMed ID: 28095810
    [Abstract] [Full Text] [Related]

  • 11. Diagnosis of 21-hydroxylase deficiency in newborn infants by GC-MS of urinary steroids.
    Yong AB, Pitt JJ, Montalto J, Davies HE, Warne GL, Connelly JF.
    Aust Paediatr J; 1988 Oct 17; 24(5):280-5. PubMed ID: 3265870
    [Abstract] [Full Text] [Related]

  • 12. Reduced activity of 11β-hydroxylase accounts for elevated 17α-hydroxyprogesterone in preterms.
    Kamrath C, Hartmann MF, Boettcher C, Wudy SA.
    J Pediatr; 2014 Aug 17; 165(2):280-4. PubMed ID: 24862381
    [Abstract] [Full Text] [Related]

  • 13. Utility of a precursor-to-product ratio in the evaluation of presumptive positives in newborn screening of congenital adrenal hyperplasia.
    Tieh PY, Yee JK, Hicks RA, Mao CS, Lee WN.
    J Perinatol; 2017 Mar 17; 37(3):283-287. PubMed ID: 27929529
    [Abstract] [Full Text] [Related]

  • 14. [Neonatal mass-screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. I. Microfilter paper methods for radioimmunoassay of 17 alpha-hydroxyprogesterone].
    Shimozawa K.
    Nihon Naibunpi Gakkai Zasshi; 1983 Dec 20; 59(12):1845-9. PubMed ID: 6609091
    [Abstract] [Full Text] [Related]

  • 15. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
    Balsamo A, Cacciari E, Piazzi S, Cassio A, Bozza D, Pirazzoli P, Zappulla F.
    Pediatrics; 1996 Sep 20; 98(3 Pt 1):362-7. PubMed ID: 8784357
    [Abstract] [Full Text] [Related]

  • 16. Cortisol in dried blood screening specimens from newborns with raised 17-hydroxyprogesterone and congenital adrenal hyperplasia.
    Mitchell ML, Hermos RJ.
    Clin Endocrinol (Oxf); 1998 Jun 20; 48(6):757-60. PubMed ID: 9713565
    [Abstract] [Full Text] [Related]

  • 17. Steroid profile in dried blood spots by liquid chromatography tandem mass spectrometry: Application to newborn screening for congenital adrenal hyperplasia in China.
    Zhan X, Han L, Qiu W, Gu X, Guo J, Chang S, Wang Y, Zhang H.
    Steroids; 2022 Sep 20; 185():109056. PubMed ID: 35660382
    [Abstract] [Full Text] [Related]

  • 18. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
    Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U, Sander J.
    J Clin Endocrinol Metab; 2007 Jul 20; 92(7):2581-9. PubMed ID: 17456574
    [Abstract] [Full Text] [Related]

  • 19. Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Pang S, Pollack MS, Loo M, Green O, Nussbaum R, Clayton G, Dupont B, New MI.
    J Clin Endocrinol Metab; 1985 Jul 20; 61(1):89-97. PubMed ID: 3873469
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.